News

  1. Aesica Delivers Advanced QP Release Services Across Multiple Dosage Forms 8/12/2013

    Aesica Pharmaceuticals has established a new Quality Assurance team focused on delivering a range of QP services across oral, topical, inhalable and parenteral dosage forms in Investigational Medicinal Products (IMP) clinical trial release, combined with the capability to assess other alternative formats as well.

  2. Pharmalink AB Receives Patent For Nefecon® Principle 10/26/2012

    Pharmalink AB announced today that it has been granted Japanese Patent No 4326696, "Methods and means for treating glomerulonephritis" for its product Nefecon(R) which is being developed to treat IgA nephropathy, a glomerulonephritis leading to end-stage renal disease (ESRD).

  3. Fujifilm Diosynth Biotechnologies Announces Strategic Alliance With Piramal Healthcare For Production Of Antibody Drug Conjugates 10/24/2012

    Fujifilm Diosynth Biotechnologies has announced it has entered into a strategic alliance with Piramal Healthcare UK Ltd, whereby the two parties will offer the seamless contract development and manufacture of antibody drug conjugates (ADCs), a growing niche in the development of biopharmaceuticals.

  4. DSM Announces Biologics Development And Manufacturing Agreement For Australian Facility 10/24/2012

    DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed a biologics contract manufacturing agreement with Paranta Biosciences Ltd of Melbourne , Australia. 

  5. AMRI Announces Five-Year Extension Of API Supply Agreement With Shire 10/18/2012

    AMRI (NASDAQ: AMRI) announced today that it has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing Inc., whose parent company, Shire plc (LSE: SHP, NASDAQ: SHPGY), is a global company that focuses its business on behavioral health, gastro intestinal diseases, rare diseases and regenerative medicine.

  6. SAGE® Labs, Ekam Imaging, Inc. Partner To Develop Preclinical Imaging Assays To Screen Therapies Of Neurodegenerative Disease 10/16/2012

    Sigma-Aldrich® Corporation (Nasdaq: SIAL) today announced that Sigma Advanced Genetic Engineering (SAGE) Labs, an initiative of Sigma®Life Science, and Ekam Imaging, Inc. have partnered to develop a suite of preclinical services based on the advanced translational power of genetically engineered rat models from SAGE Labs and Ekam's expertise in functional magnetic resonance imaging (fMRI) technology. For more information on SAGE Labs, visit www.sageresearchmodels.com

  7. Vetter Receives Top Prize At The European Outsourcing Awards Ceremony 10/15/2012

    Vetter has been awarded first place for the category Most Improved Manufacturing Project or Process at this year’s European Outsourcing Awards. The application for the company’s new high-speed filling line for pre-sterilized syringes was the top choice among the jury of experts due to its intelligent concepts and systems. The award was given to the company at a gala dinner on October 10, during the CPHI Worldwide/iCSE show in Madrid.

  8. Aptalis Pharmaceutical Technologies Sponsors AAPS Research Achievement Awards In Pharmacokinetics, Pharmacodynamics And Drug Metabolism At AAPS Annual Meeting And Exposition 10/11/2012

    Aptalis Pharmaceutical Technologies, formerly Eurand, focused on developing differentiated oral products utilizing its pharmaceutical technologies, recently announces its sponsorship of the American Association of Pharmaceutical Scientists (AAPS) Research Achievement Awards in Pharmacokinetics, Pharmacodynamics and Drug Metabolism and its participation in the 2012 AAPS Annual Meeting and Exposition October 14 – 18, 2012 in Chicago, Illinois. 

  9. Symbiosis Launches Multi-Million Pound Sterile Drug Manufacturing Capability In Scotland 10/9/2012

    Symbiosis Pharmaceutical Services Limited, an MHRA-approved sterile manufacturing facility based in Stirling, Scotland is an exciting, young company specializing in the small-scale manufacture of sterile pharmaceuticals for clinical trials (fill/finish).